Table 2 |
|||
|
An overview of typical concentrations of toxic organic compounds reported in non-invasive human matrices (arithmetic mean (rangea)) |
|||
|
Hexachlorobenzene (HCB) (ng/g lipid) |
PCDD/F (in pg TEQ/g lipid) |
Cotinine (in non-smokers) |
|
|
|
|||
|
Urine (μg/l) |
PCP: 3.8 (0.6–18.0)c PCBT: 8.8 (0.5–86.9)c [57] |
- |
17.9 (ND-3400) [37] |
|
Urine (μg/g creatinine) |
- |
- |
17.1 (ND-5810) [37] |
|
Placenta (ng/g wet weight) |
7.7b (2.2–26.5) [49] |
31 (10–74) [47] |
- |
|
Cord blood (μg/l) |
0.73 (0.14–9.82) [50] |
14 (3.7–32) [47] |
3.08 (ND-910) [51] |
|
Exhaled breath (μg/l) |
- |
- |
21 (ND-42)e [59] |
|
Breast milk (ng/g lipid) |
12.4 (6.01–24.56) [49] |
9.5 (2.7–51.5) [52] |
0.2 (0.03–1.3) [53] |
|
Hair (μg/g) |
28 (20–32)d [89] |
- (0.25–230) [26] |
0.29 (ND-11) [45] |
|
|
|||
|
a Range may include high levels at which adverse effects are expected; b Arithmetic mean (P10-P95); c Metabolites of HCB, expressed in μg/24 h; d Median (P25-P75); e Cotinine in saliva; f ND: below detection limit |
|||
|
Smolders et al. Environmental Health 2009 8:8 doi:10.1186/1476-069X-8-8 |
|||
